Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone lysine methyltransferases in biology and disease
Dylan Husmann, Or Gozani
Nature Structural & Molecular Biology (2019) Vol. 26, Iss. 10, pp. 880-889
Open Access | Times Cited: 374

Showing 1-25 of 374 citing articles:

The language of chromatin modification in human cancers
Shuai Zhao, C. David Allis, Gang Greg Wang
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 413-430
Open Access | Times Cited: 293
Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease
Kamakoti P. Bhat, H. Ümit Kanıskan, Jian Jin, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 4, pp. 265-286
Open Access | Times Cited: 177
The role of histone modifications: from neurodevelopment to neurodiseases
Jisu Park, Kyubin Lee, Kyunghwan Kim, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 156
Elevated NSD3 histone methylation activity drives squamous cell lung cancer
Gang Yuan, Natasha Flores, Simone Hausmann, et al.
Nature (2021) Vol. 590, Iss. 7846, pp. 504-508
Open Access | Times Cited: 116
Histone editing elucidates the functional roles of H3K27 methylation and acetylation in mammals
Aditya Sankar, Faizaan Mohammad, Arun Kumar Sundaramurthy, et al.
Nature Genetics (2022) Vol. 54, Iss. 6, pp. 754-760
Closed Access | Times Cited: 103
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies
Xiumei Wu, Mengyun Xu, M. Geng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 98
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Zhenyi Niu, Runsen Jin, Yan Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 95
Cancer epigenetics: from laboratory studies and clinical trials to precision medicine
Xinyang Yu, Hao Zhao, Ruiqi Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 94
Epigenetic mechanisms of Immune remodeling in sepsis: targeting histone modification
Dan Wu, Yuxin Shi, Hao Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 50
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases
Wanqiu Li, Wei Tian, Gang Yuan, et al.
Nature (2020) Vol. 590, Iss. 7846, pp. 498-503
Open Access | Times Cited: 116
Role of Rad51 and DNA repair in cancer: A molecular perspective
Erik Laurini, Domenico Marson, Alice Fermeglia, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107492-107492
Open Access | Times Cited: 88
Targeting post-translational histone modifying enzymes in glioblastoma
Elena Kunadis, Eleftheria Lakiotaki, Penelope Korkolopoulou, et al.
Pharmacology & Therapeutics (2020) Vol. 220, pp. 107721-107721
Closed Access | Times Cited: 83
SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy
Zhentian Wang, Simone Hausmann, Ruitu Lyu, et al.
Cancer Cell (2020) Vol. 37, Iss. 6, pp. 834-849.e13
Open Access | Times Cited: 75
Histone lysine demethylases and their functions in cancer
Jayden Sterling, Sharleen V. Menezes, Ramzi H. Abbassi, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 10, pp. 2375-2388
Open Access | Times Cited: 74
NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis
Deepanwita Sengupta, Liyong Zeng, Yumei Li, et al.
Molecular Cell (2021) Vol. 81, Iss. 21, pp. 4481-4492.e9
Open Access | Times Cited: 72
Epigenetic Mechanisms of Neural Plasticity in Chronic Neuropathic Pain
Krishna Ghosh, Hui‐Lin Pan
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 4, pp. 432-441
Closed Access | Times Cited: 55
KMT2A: Umbrella Gene for Multiple Diseases
Silvia Castiglioni, Elisabetta Di Fede, Clara Bernardelli, et al.
Genes (2022) Vol. 13, Iss. 3, pp. 514-514
Open Access | Times Cited: 41
The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors
Iuliia Topchu, Rajendra P. Pangeni, Igor Bychkov, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 40
Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA
Joanna Szczepanek, Monika Skorupa, Joanna Jarkiewicz‐Tretyn, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7235-7235
Open Access | Times Cited: 38
Epigenetic reprogramming in cancer: From diagnosis to treatment
Pedro M. S. Costa, Sarah Leyenne Alves Sales, Daniel Pascoalino Pinheiro, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 35
Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2
Ronan P. Hanley, Yan Nie, John R. Tabor, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 14, pp. 8176-8188
Closed Access | Times Cited: 35
Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia
Mateusz Górecki, Ilona Kozioł, Agnieszka Kopystecka, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 821-821
Open Access | Times Cited: 30
Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies
Xiaopeng Peng, Zhihao Hu, Limei Zeng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 533-578
Open Access | Times Cited: 25
Epigenetic Modulators as Therapeutic Agents in Cancer
Eshaan Patnaik, Chikezie O. Madu, Yi Lü
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14964-14964
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top